advertisement
Sung KR 23
Showing records 1 to 23 | Display all abstracts from Sung KR96102 Effect of Postoperative Trimming of the Tube Portion of Ahmed Glaucoma Valve on Corneal Endothelial Cell Loss
Lee KE
Journal of Glaucoma 2022; 31: 102-108
96352 Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Kim JM
International Journal of Ophthalmology 2021; 14: 1539-1547
95553 Implications of the Relationship Between Refractive Error and Biometry in the Pathogenesis of Primary Angle Closure
Shon K
Investigative Ophthalmology and Visual Science 2021; 62: 38
95664 Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Kim ML
International journal of molecular sciences 2021; 22:
96033 Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Sakata R; Chang PY
Seminars in Ophthalmology 2021; 0: 1-8
96352 Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Sung KR
International Journal of Ophthalmology 2021; 14: 1539-1547
96102 Effect of Postoperative Trimming of the Tube Portion of Ahmed Glaucoma Valve on Corneal Endothelial Cell Loss
Sung KR
Journal of Glaucoma 2022; 31: 102-108
95553 Implications of the Relationship Between Refractive Error and Biometry in the Pathogenesis of Primary Angle Closure
Sung KR
Investigative Ophthalmology and Visual Science 2021; 62: 38
95664 Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Sung KR
International journal of molecular sciences 2021; 22:
96352 Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Lee JW
International Journal of Ophthalmology 2021; 14: 1539-1547
96102 Effect of Postoperative Trimming of the Tube Portion of Ahmed Glaucoma Valve on Corneal Endothelial Cell Loss
Shin JW
Journal of Glaucoma 2022; 31: 102-108
95553 Implications of the Relationship Between Refractive Error and Biometry in the Pathogenesis of Primary Angle Closure
Yoon JY
Investigative Ophthalmology and Visual Science 2021; 62: 38
95664 Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Kwon J
International journal of molecular sciences 2021; 22:
96033 Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Sung KR
Seminars in Ophthalmology 2021; 0: 1-8
96352 Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Kyung H
International Journal of Ophthalmology 2021; 14: 1539-1547
95664 Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Choi GW
International journal of molecular sciences 2021; 22:
96033 Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Kim TW
Seminars in Ophthalmology 2021; 0: 1-8
95664 Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Shin JA
International journal of molecular sciences 2021; 22:
96033 Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Wang TH
Seminars in Ophthalmology 2021; 0: 1-8
96352 Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Rho S
International Journal of Ophthalmology 2021; 14: 1539-1547
96033 Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Perera SA
Seminars in Ophthalmology 2021; 0: 1-8
96352 Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Kim CY
International Journal of Ophthalmology 2021; 14: 1539-1547
96033 Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Cantor LB
Seminars in Ophthalmology 2021; 0: 1-8
